Nanomedicine strategies for cuproptosis: Metabolic reprogramming and tumor immunotherapy
Acta Pharmaceutica Sinica B · 2025-09 · 15 (9) · 4582-4613
DOI: 10.1016/j.apsb.2025.07.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2025-09. Verfasst von Ruixuan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 310 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tianjin University, Shandong University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
- College of Integrated Chinese and Western Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
- Experimental Teaching and Practical Training Center, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
- College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Förderung
- Tianjin University
- Shandong University
- National Natural Science Foundation of China
Zitieren
APA
Zhang, R., Li, Y., Fu, H., Zhao, C., Li, X., Wang, Y., Sun, Y., & Li, Y. (2025). Nanomedicine strategies for cuproptosis: Metabolic reprogramming and tumor immunotherapy. Acta Pharmaceutica Sinica B, 15(9), 4582-4613. https://doi.org/10.1016/j.apsb.2025.07.007
Vancouver
Zhang R, Li Y, Fu H, Zhao C, Li X, Wang Y, et al. Nanomedicine strategies for cuproptosis: Metabolic reprogramming and tumor immunotherapy. Acta Pharmaceutica Sinica B. 2025;15(9):4582-4613. doi:10.1016/j.apsb.2025.07.007
BibTeX
@article{Zhang2025,
author = {Zhang, Ruixuan and Li, Yunfei and Fu, Hui and Zhao, Chengcheng and Li, Xiuyan and Wang, Yuming and Sun, Yujiao and Li, Yingpeng},
title = {Nanomedicine strategies for cuproptosis: Metabolic reprogramming and tumor immunotherapy},
journal = {Acta Pharmaceutica Sinica B},
year = {2025},
volume = {15},
number = {9},
pages = {4582--4613},
doi = {10.1016/j.apsb.2025.07.007}
}
EUVIMED